SkinBioTherapeutics pleased with progress on two fronts
10th May 2023 13:05
(Sharecast News) - Skin health-focussed life science company SkinBioTherapeutics said in an update on Wednesday that its partner Sederma, a division of Croda International, was planning to undertake additional studies on SkinBiotix.
Read moreSkinBioTherapeutics reports progress with psoriasis supplement roll-out
17th Feb 2022 15:34
(Sharecast News) - SkinBioTherapeutics updated the market on Thursday on the commercialisation of its food supplement product 'AxisBiotix-Ps', designed for the symptoms of psoriasis.
Read moreSkinBioTherapeutics commercially launches psoriasis supplement
29th Oct 2021 12:48
(Sharecast News) - Skin health-focussed life sciences company SkinBioTherapeutics announced the commercial launch of 'AxisBiotix-Ps' on Friday, which it described as a probiotic food supplement to help alleviate the symptoms of psoriasis.
Read moreSkinBioTherapeutics confirms launch plans for psoriasis supplement
30th Sep 2021 15:38
(Sharecast News) - Skin health-focussed life science company SkinBioTherapeutics updated the market on its commercialisation plans for 'AxisBiotix-Ps' on Thursday, which it described as its probiotic food supplement to help alleviate the symptoms associated with psoriasis.
Read moreSkinBioTherapeutics launches research programme with Manchester University
8th Apr 2021 13:01
(Sharecast News) - Skin health science company SkinBioTherapeutics has initiated a research programme with the University of Manchester, it announced on Thursday, to investigate and develop microbiome formulations that support natural anti-inflammatory response to a range of environmental challenges.
Read moreSkinBioTherapeutics confident in timelines amid Covid crisis
7th Jul 2020 13:42
(Sharecast News) - SkinBioTherapeutics updated the market on its operations on Tuesday, reporting that it ended the 12 months to 30 June with a "solid" cash balance of £2.1m, down from £2.5m at the end of December.
Read moreSkinBioTherapeutics to develop psoriasis supplement with Winclove
19th Feb 2020 14:48
(Sharecast News) - Skin health-focussed life science company SkinBioTherapeutics announced on Wednesday that its wholly-owned subsidiary, AxisBiotix, has signed a development agreement with Winclove Probiotics, to help manage the symptoms associated with the skin condition, psoriasis.
Read moreSkinBioTherapeutics strikes deal with chemicals giant Croda
20th Nov 2019 11:15
(Sharecast News) - Skin health-focussed life sciences company SkinBioTherapeutics has signed a commercial agreement with speciality chemicals giant Croda International, it announced on Wednesday.
Read moreSkinBioTherapeutics pleased with first human study results
8th Apr 2019 09:08
(Sharecast News) - Skin health-focussed life sciences company SkinBioTherapeutics released the results of its first human study on Monday, which was primarily undertaken to show the effects of its 'SkinBiotix' product on the barrier of healthy skin.
Read moreSkinBio seeking 'commercially experienced' CEO as business evolves
14th Feb 2019 10:40
(Sharecast News) - SkinBioTherapeutics on Thursday announced that it is seeking a "commercially experienced" replacement for Cath O'Neill, as she transitions away from the chief executive role during the current year.
Read moreSkinbio begins human studies of moisturising cream
25th Oct 2018 08:28
(Sharecast News) - The past year has seen SkinBioTherapeutics make "significant progress" with the development of its moisturising cream and efforts to begin human trials, the company said on Thursday.
Read moreSkinBioTherapeutics begins human study on SkinBiotix
19th Sep 2018 14:57
(Sharecast News) - Life science company SkinBioTherapeutics has commenced its human study being carried out on its 'SkinBiotix' technology, it announced on Wednesday.
Read moreSkinBioTherapeutics to begin human study this month
3rd Sep 2018 15:23
(Sharecast News) - Life science company SkinBioTherapeutics updated the market on its stability testing on Monday, reporting that the stability criteria required for its human study had been met.
Read moreSkinBioTherapeutics achieves 'significant' manufacturing scale-up
16th Aug 2018 15:39
(Sharecast News) - Skin health-focussed life science company SkinBioTherapeutics updated the market on Thursday, reporting that it had now achieved "significant" manufacturing scale up with its third party manufacturer, with no detrimental impact upon the active properties of the 'SkinBiotix' technology.
Read more